Page last updated: 2024-09-04

ym 872 and Atrophy

ym 872 has been researched along with Atrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyata, K; Sasamata, M; Suzuki, M; Terai, K; Yamaguchi, T; Yatsugi, Si1
Ni, JW; Shimizu-Sasamata, M; Takahashi, M; Yamaguchi, T; Yatsugi, S1

Other Studies

2 other study(ies) available for ym 872 and Atrophy

ArticleYear
Effect of AMPA receptor antagonist YM872 on cerebral hematoma size and neurological recovery in the intracerebral hemorrhage rat model.
    European journal of pharmacology, 2003, Apr-25, Volume: 467, Issue:1-3

    Topics: Animals; Atrophy; Brain Edema; Brain Infarction; Cerebral Hemorrhage; Collagenases; Dose-Response Relationship, Drug; Hematoma; Heparin; Imidazoles; Male; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA

2003
Effects of YM872 on atrophy of substantia nigra reticulata after focal ischemia in rats.
    Neuroreport, 1998, Nov-16, Volume: 9, Issue:16

    Topics: Animals; Arterial Occlusive Diseases; Atrophy; Body Temperature; Body Weight; Brain Ischemia; Cerebral Infarction; Imidazoles; Male; Neurologic Examination; Neuroprotective Agents; Quinoxalines; Rats; Rats, Inbred F344; Receptors, AMPA; Substantia Nigra

1998